Common Stock, Shares, Issued of Applied Therapeutics, Inc. from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Applied Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and change rate from Q4 2018 to Q3 2025.
  • Applied Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending 30 Sep 2025 was 144M shares, a 24% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Applied Therapeutics, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 144M +27.9M +24% 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 142M +27.1M +23.6% 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 142M +27.3M +23.9% 31 Mar 2025 10-Q 14 May 2025
Q4 2024 137M +52.4M +61.7% 31 Dec 2024 10-Q 13 Nov 2025
Q3 2024 116M +39.2M +50.9% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 115M +52.7M +84.9% 30 Jun 2024 10-Q 07 Aug 2024
Q1 2024 114M +66.1M +137% 31 Mar 2024 10-Q 09 May 2024
Q4 2023 84.9M +36.8M +76.6% 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 77.1M +29.1M +60.5% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 62.1M +15.9M +34.3% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 48.1M +21.9M +83.5% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 48.1M +21.8M +83.3% 31 Dec 2022 10-K 06 Mar 2024
Q3 2022 48.1M +21.8M +83.3% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 46.3M +20.1M +77% 30 Jun 2022 10-Q 12 Aug 2022
Q1 2022 26.2M +205K +0.79% 31 Mar 2022 10-Q 12 May 2022
Q4 2021 26.2M +3.72M +16.5% 31 Dec 2021 10-K 23 Mar 2023
Q3 2021 26.2M +3.76M +16.7% 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 26.1M +3.8M +17% 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 26M +4.04M +18.4% 31 Mar 2021 10-Q 11 May 2021
Q4 2020 22.5M +3.96M +21.4% 31 Dec 2020 10-K 10 Mar 2022
Q3 2020 22.5M +5.32M +31.1% 30 Sep 2020 10-Q 12 Nov 2020
Q2 2020 22.3M +5.28M +31% 30 Jun 2020 10-Q 11 Aug 2020
Q1 2020 22M +16.5M +298% 31 Mar 2020 10-Q 11 May 2020
Q4 2019 18.5M +13M +236% 31 Dec 2019 10-K 18 Mar 2021
Q3 2019 17.1M 30 Sep 2019 10-Q 13 Nov 2019
Q2 2019 17.1M 30 Jun 2019 10-Q 12 Aug 2019
Q1 2019 5.51M 31 Mar 2019 10-Q 21 Jun 2019
Q4 2018 5.51M 31 Dec 2018 10-K 13 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.